According to a new report, published by KBV research, The Global Vascular Patches Market size is expected to reach $529 Million by 2028, rising at a market growth of 7.1% CAGR during the forecast period.
The Synthetic segment is showcasing a CAGR of 8.2% during (2022 - 2028). The synthetic vascular patches is likely to grow at a fastest rate over the projected period. Polyethylene terephthalate (PET) and polytetrafluoroethylene (PTFE) are examples of synthetic materials for vascular patches that are ready to use, have a long shelf life, good biomechanical strength, and maybe lower risk of patch rupture.
The Hospitals segment acquired maximum revenue share in the Global Vascular Patches Market by End User in 2021 thereby, achieving a market value of $377 Million by 2028. The expansion of the hospital and clinic segment was primarily caused by the availability of infrastructure and the rise in the number of vascular surgeries.
The Open Repair of Abdominal Aortic Aneurysm segment has shown the growth rate of 7.3% during (2022 - 2028). It has been established that open repair of abdominal aortic aneurysms is safe, widely accessible, effective in preventing aneurysm rupture, and notably durable. Under general anesthesia, open abdominal aortic aneurysm repair is performed with appropriate volume status control, fluid administration, and transfusion as needed.
The North America market dominated the Global Vascular Patches Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $197.4 Million by 2028. The Europe market is experiencing a CAGR of 6.8% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 7.9% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/vascular-patches-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Edwards Lifesciences Corporation, Baxter International, Inc., Lemaitre Vascular, Inc., Becton, Dickinson and Company, Terumo Corporation, Aziyo Biologics, Inc., Getinge AB, B. Braun Melsungen AG, Artivion, Inc. (CryoLife, Inc.), and W. L. Gore & Associates, Inc.
By Material
By End User
By Application
By Geography
Companies Profiled
Unique Offerings 
